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 Chapter 6 
 Bioactive Nanomaterials for Neural 
Engineering 
 Melike  Sever ,  Idil  Uyan ,  Ayse  B.  Tekinay , and  Mustafa  O.  Guler 
6.1  Introduction 
6.1.1  Nerve Regeneration and the Roles of Extracellular 
Matrix Elements 
 Nervous system is a highly  co mplex interconnected network and higher organisms 
including humans have limited neural regeneration capacity. Neurodegenerative 
diseases result in signifi cant cognitive, sensory, or motor impairments. Following 
an injury in the neural network, there is a balance between promotion and inhibi-
tion of regeneration and this balance is shifted to different directions in central 
nervous system (CNS) and peripheral nervous system (PNS). More regeneration 
capacity is observed in the PNS compared to the CNS. Although, several mecha-
nisms play roles in the inhibitory and growth-promoting natures of the CNS and 
PNS, extracellular matrix (ECM) elements are key players in this process. ECM is 
a three- dimensional environment where the cells migrate, proliferate, and differ-
entiate (Rutka et al.  1988 ; Pan et al.  1997 ). After a comprehensive investigation of 
the interactions between the ECM proteins and cell receptors, the ECM environ-
ment was found to regulate signifi cant cellular processes such as survival, prolif-
eration, differentiation, and migration (Yurchenco and Cheng  1994 ; Aszodi et al. 
 2006 ). Its components have major roles not only in neurogenesis during develop-
ment of the nervous system but also in normal neural functioning during adulthood 
(Hubert et al.  2009 ). 
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6.1.1.1  Peripheral Nervous System 
 In the PNS, neurons (axons) and  Schwann cells are the major cellular elements. 
Endoneurium tissue is the connective tissue that surrounds individual axon-Schwann 
cell units, whereas perineurium covers a fascicle of axons. Perineurium also acts as 
a barrier against fl uxes of ionic and macromolecular compounds between connec-
tive and vascular tissues and endoneurium (Siegel et al.  1999 ).  Epineurium is the 
outermost connective tissue, which covers the entire nerve (Bunge et al.  1989 ). In 
the endoneurium, Schwann cells are abundant, whereas fi broblasts form 10 % of the 
cell population (Verheijen et al.  2003 ). Myelination after axonal regeneration has a 
central role for functional outcomes, and proper ECM formation has strong infl u-
ence on this process (Bunge  1993 ). 
 Basal lamina of PNS contains laminin, fi bronectin, entactin, and heparan sulfate 
proteoglycans (Bunge  1993 ) and collagens (Shellswell et al.  1979 ).  Laminin is syn-
thesized by the Schwann cells, and it is considered to have the leading bioactivity in 
terms of growth, adhesion, and migration of these cells (Milner et al.  1997 ).  Laminin 
has also been shown to have a critical effect on myelination during peripheral nerve 
regeneration in culture systems (Tsiper and Yurchenco  2002 ). As another basal 
lamina element, collagen is the major ECM protein and it is produced mostly by the 
fi broblasts and Schwann cells in fi brillary and nonfi brillar forms (Koopmans et al. 
 2009 ). Fibrous types of collagens: collagen I, III, and V are found in all three 
ensheathing layers of peripheral nerve tissue. Collagen type-I and III are present in 
small diameters in the external face of Schwann cell basal lamina, whereas collagen 
type-V colocalizes with them in addition to enveloping myelinating Schwann cells 
in the basal lamina (Chernousov et al.  2006 ). Schwann cells also produce a more 
glycosylated and nonfi brillar type of collagen, collagen IV, which is a principle 
component of basal lamina. Collagen IV has a role in integrating laminin, perlecan, 
nidogen, and other ECM proteins into a supramolecular structure (Hudson et al. 
 1993 ) in the basal lamina surrounding Schwann cells, the perineurial cells, and 
endoneurial capillaries (Koopmans et al.  2009 ). Fibroblasts produce a fi brillary net-
work of collagens and provide the framework required for Schwann cell ensheath-
ment of regenerating axons (Eather et al.  1986 ). Fibronectin is another important 
ECM protein that has a very defi ned and specifi c expression pattern to guide neuro-
nal outgrowth (Sheppard et al.  1991 ). Interaction of fi bronectin with collagen, hepa-
rin, fi brin, and integrins via its specifi c domains results in cellular responses 
including cell adhesion, Schwann cell motility, and growth (Ahmed and Brown 
 1999 ).  Chondroitin sulfate proteoglycans (CSPG) are also abundant in the Schwann 
cell ECM; however, they show inhibitory activity in contrast to other ECM ele-
ments in the PNS tissue (Braunewell et al.  1995 ). 
 Although complete recovery of PNS is not common, especially for large gaps, 
PNS injury environment is more permissive for regeneration compared to 
CNS. Nonneuronal cells respond to injury and start a key event called “Wallerian 
degeneration” (Waller  1850 ). This process initiates a series of events, which 
together help clearance of inhibitory myelin debris and promotion of axon regrowth 
(Griffi n et al.  1995 ).  Axon degeneration starts several days after the injury, leaving 
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the tissues denervated (Gilliatt and Hjorth  1972 ). When calcium starts to infl ux 
from the ECM and internal Ca 2+ stores to the injured axon (Stirling and Stys  2010 ), 
calpain is activated, a protease, which functions in cytoskeletal degradation and 
axonal degeneration (Wang et al.  2004 ). Schwann cells and fi broblasts secrete 
tropic and tropic factors, and detached Schwann cells go through proliferation. The 
basal lamina remains and guides endoneurium toward the distal site (Fu and Gordon 
 1997 ). Schwann cells form Bands of Büngner with the help of fi brin cables, where 
fi broblasts and blood vessels can also use as a guiding surface (Williams et al. 
 1983 ). Fibrin is later replaced by collagens produced by fi broblasts and laminin 
secreted by Schwann cells. Regeneration fails when the initial fi brin cable cannot be 
formed due to a large gap (Yannas et al.  2007 ). 
6.1.1.2  Central Nervous System 
 Apart from the neurons and glial  cells , ECM constitutes 10–20 % volume of the 
CNS (Bignami et al.  1993 ). While specifi c pathfi nding, migration, and differentia-
tion of the cells are regulated by specifi c ECM proteins during CNS development 
(Bandtlow and Zimmermann  2000 ), ECM components play role in stabilization of 
the structure, regulation of the synaptic plasticity, and prevention of aberrant synap-
tic remodeling throughout the adulthood (Dityatev and Schachner  2003 ). The 
matrix forms a dense network of proteins and glycans, facilitating the organization 
of the cells as well as providing structural support to them (Lau et al.  2013 ). Basal 
lamina, perineuronal nets, and interstitial matrix form the ECM structurally. 
Basement membrane is the tissue that covers the entire pial surface of the CNS and 
it comprises of collagen, laminin, nidogen, fi bronectin, dystroglycan, and perlecan. 
On the contrary, the matrix surrounding the neurons, perineuronal nets, have a net-
work majorly made up of proteoglycans,  tenascin R , and other proteins (Kwok et al. 
 2011 ), which conserve and maintain synaptic plasticity. Interstitial network is 
formed by proteoglycans, hyaluronan, tenascins, and other linking proteins (Rauch 
 2007 ). Moreover, collagen, elastin, laminin, and fi bronectin also participate in the 
structure of the network, however in smaller amounts (Lau et al.  2013 ). 
 Following a damage to the CNS, a series of molecular and cellular events occur 
resulting in inhibition of regeneration process. Glial scar tissue formation is trig-
gered by the entrance of non-CNS elements to the CNS. Although it leads to inhibi-
tion of regeneration, one important benefi cial role of glial scar is to preserve the 
damaged tissue, repair the blood–brain barrier (BBB), and minimize cellular degen-
eration and infl ammatory burden (Silver and Miller  2004 ; Bush et al.  1999 ). First, 
macrophages migrate to the injury site from the blood due to BBB disruption. Then, 
oligodendrocyte precursors migrate to the injury site in massive numbers. Finally, 
astrocytes proliferate and migrate to the area to fi ll in the injury area and become 
reactive, which is a process called “reactive astrogliosis” (Fawcett and Asher  1999 ). 
Reactive astrocytes produce glial fi brillary acidic protein (GFAP) after CNS injury, 
which can also be used as a marker for glial scar formation. Although GFAP pro-
duction is similar to collagen fi bers, they are important in regeneration process. 
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ECM of CNS is composed of protein or proteoglycan-based aggregates, whereas 
native PNS ECM has a fi brous structure (Alovskaya et al.  2007 ). 
 Besides producing growth promoting factors, astrocytes also produce four dif-
ferent types of proteoglycans, which are made up of a core protein and sulfated 
glycosaminoglycan chains attached to the sides that are inhibitory to regeneration: 
heparan sulfate proteoglycan (HSPG), dermatan sulfate proteoglycan (DSPG), ker-
atan sulfate proteoglycan (KSPG), and CSPG (Larsen et al.  2003 ). Hyaluronic acid 
is another carbohydrate, which is also present in the ECM of CNS. It interacts with 
proteoglycans to form a mesh-like structure in the perineuronal network (Kwok 
et al.  2010 ). During development, CSPG plays a role in inhibitory patterning of 
neuronal pathway (Tang et al.  2003 ). In healthy adult perineuronal networks, they 
are involved in stabilization of synaptic plasticity (Hunanyan et al.  2010 ). However, 
upregulated levels of  CSPGs are known to increase glial scar in the mature spinal 
cord and brain (Becker and Becker  2002 ), and they inhibit neurite outgrowth exten-
sively in vitro (Sharma et al.  2012 ). They are upregulated within 24 h following 
injury and they remain at the injury site for months (McKeon et al.  1999 ; Jones et al. 
 2003 ). Mechanism of  CSPGs inhibition is thought to be both nonspecifi c, through 
the contact of negatively charged glycosaminoglycan chains, and specifi c through 
signaling mechanisms by interacting with PTP and receptors (Dickendesher et al. 
 2012 ; Sharma et al.  2012 ). 
6.1.2  Blood–Brain Barrier and Blood–Spinal Cord Barrier 
 BBB and  blood–spinal cord barrier (BSCB)  are  mechanisms that act as shields 
between CNS and blood and they preserve homeostasis in organisms with well- 
developed CNS (Abbott  2005 ). Even though they have similar morphological 
characteristics and functions such as preservation of CNS, BBB and BSCB are con-
sidered to be different processes. Both BBB and BSCB are composed of nonfenes-
trated endothelial cells, basement membrane, pericytes, and astrocytic end processes. 
Endothelial cells have tight junctions via claudin, occludin, and adherens junction 
molecules (Abbott et al.  2006 ). BSCB differs from BBB in terms of permeability of 
different molecules. Furthermore, there are glycogen deposits in the microvessels, 
which are not present on the cerebral vascular structure (Sharma  2005 ) and are 
thought to serve as an endogenous energy source. Cellular components of BBB are 
microvascular endothelium, astrocytes, basement membrane, pericytes, and the 
neurons that are in physical proximity to the microvascular endothelial cells. The 
neurons in the brain and the spinal cord communicate through chemical signals via 
neurotransmitters and modulators, and electrical signals via synaptic potentials and 
action potentials, which form a complex network. Ionic movements across the neu-
ronal membranes are involved in the signaling processes. There are also the ionic 
fl uxes, which maintain the resting membrane potentials stable and the ionic move-
ments involved with electrochemical signals are transmitted on this background of 
ionic fl uxes. In order for signal transmission to be precise, reliable, and consistent, 
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ionic composition of the brain extracellular milieu needs to be preserved against the 
rapid fl uctuations of ionic composition in the blood caused by physical exercise or 
food intake. There is evolutionary evidence that ionic movements were the major 
factor driving barriers between CNS and blood, and the barriers gained other func-
tions subsequently (Abbott  1992 ). 
 Brain microvascular endothelial cells (BMVEC) are responsible for regulation 
of function such as transportation of micro and macronutrients, receptor-mediated 
signaling, regulation of osmotic pressure, and leukocyte traffi cking. They impede 
free exchange of solutes (Ohtsuki and Terasaki  2007 ) with the exception of lipid- 
soluble molecules smaller than 400 Da with less than nine hydrogen bonds, which 
are able to cross BBB via lipid mediated diffusion (Pardridge  2007 ). Structurally, 
the cells are connected to each other via tight junctions (TJs), adherens junctions 
(AJs) (Hawkins and Davis  2005 ), and  gap junctions (Boulay et al.  2015 ), which are 
required for the compact characteristics of the barrier. Their main role is to restrict 
passage of unwanted molecules between blood and brain by forming a continuous 
layer of membrane that does not contain fenestrae, which are normally found on 
the endothelial cells of blood vessels for rapid exchange of molecules. Along with 
the physical barrier created by junctional elements and low transcytotic activity, 
endothelial cells also create an enzymatic barrier against potential lipophilic sub-
stances, such as lipophilic drugs and toxic substances (El-Bacha and Minn  1999 ), 
which provides a metabolic barrier to the brain (El-Bacha and Minn  1999 ). Neurons 
at the periphery are connected through astrocytic interactions to the BBB (Abbott 
et al.  2006 ) and together with the other neovascular unit elements (astrocytes and 
pericytes), they provide required paracrine signals to the endothelium (Deane and 
Zlokovic  2007 ) and control BBB permeability, structure, and function (Abbott 
et al.  2006 ). 
 The CNS barriers protect nervous system homeostasis and they control molecu-
lar traffi c, toxins, neuronal signaling, low protein environment in CNS, and neuro-
nal circuits. They reduce cross talk by separation of central and peripheral 
neurotransmitter pools and ensuring minimal infl ammatory response and functional 
impairment during immune surveillance (Abbott  2013 ). 
6.1.3  Challenges in Engineering Biomaterials for Nervous 
System Repair 
 Following a nervous system injury, regeneration capacity usually depends  on  the 
extent of the injury, the distance of the injury to the cell body, and biological status 
of the patient (morbidity, age, etc.) (Faroni et al.  2015 ). The PNS and CNS respond 
to injury in their own unique way. In the PNS, Wallerian degeneration occurs in the 
distal end following a series of pathophysiological events. The distal portion of the 
nerve is degenerated and the cellular debris is digested by the macrophages and 
monocytes (Stoll et al.  1989 ). Schwann cells form the Bands of Büngner in order to 
guide regenerating axonal sprouts to its synaptic target (Chaudhry et al.  1992 ; 
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Schmidt and Leach  2003 ). During the extension process, bridging the gap between 
the two ends and optimizing the environment physically, chemically, and biologi-
cally is a strategy that has been followed (Schmidt and Leach  2003 ). In PNS, the 
challenge is to fi nd a perfect alternative to autologous nerve grafts: eliminating risks 
of secondary surgeries and precluding secondary damage on the body. Even though 
structural plasticity is achieved clinically, functional plasticity does not always 
reach complete state and it still is another principal consideration in PNS regenera-
tion studies. Autologous nerve graft treatment shows 50 % clinical functional recov-
ery (Lee and Wolfe  2000 ). Furthermore, use of natural proteins for therapeutic 
purposes can cause immunogenic reactions. Sustained delivery or storage of growth 
factors are also required in order for effective usage of growth factors (Schmidt and 
Leach  2003 ). 
 CNS has much smaller capacity to regenerate; thus, CNS therapies are more 
challenging. Embryonic spinal cord and peripheral nerve grafts have been shown to 
support regeneration of CNS fi bers, however failed to successfully grow through 
the CNS–PNS transition zone (Bernstein and Goldberg  1995 ) (Carlstedt  1997 ). 
CNS does not have a permissive nature for regeneration. There are many reasons 
behind the obstructive environment of CNS injuries. Regeneration-associated genes 
are expressed at low levels in the CNS (Bulsara et al.  2002 ). Following the CNS 
injury, glial scar is formed and inhibitory molecules are released at the site of injury. 
Cellular debris and inhibitory myelin components are cleared much slowly com-
pared to the PNS as a result of low infi ltration levels of macrophages through the 
brain–spinal cord barrier (Avellino et al.  1995 ). Moreover, astrocytes proliferate at 
the site of injury, in a similar way to Schwann cell proliferation, however, in con-
trast, creating an inhibitory environment and becoming reactive astrocytes (McKeon 
et al.  1991 ). Thus, nerve regeneration studies focus on suppressing the inhibitory 
nature of the nervous system injuries and future directions in PNS and CNS repair 
include combining multiple cues at a time to increase the regeneration capacity 
(Schmidt and Leach  2003 ). BBB is another obstacle for drug delivery to the brain, 
considering that intracranial injections are much more invasive than other adminis-
tration (i.e., intravenous, oral) methods. Another challenge for drug delivery is 
accurate targeting of the correct population of the cells. 
6.2  Biomaterial Design for Peripheral Nerve Repair 
 PNS injuries most commonly caused  by trauma (Ichihara et al.  2008 ), bone frac-
tures, or joint dislocations (Zumwalt and Wooldridge  2014 ). They result in partial 
loss of sense or motor function in the distal segment of the injured axon (Navarro 
et al.  2007 ). The potential to achieve functional recovery depends on the severity of 
the damage at the axon, nerve tube, or connective tissues at the injury site, timing of 
the surgery, surgical technique used, and postoperational rehabilitation (Lanaras 
et al.  2009 ; Barton et al.  2014 ). 
 As a clinical strategy, the two ends of the nerve are sutured if the gap between 
the distal and proximal end is <2 cm. However, other alternatives are considered in 
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cases of nerve segmental loss with a consequent gap longer than 2 cm because of 
the tension that emerges when two ends are sutured to each other (Johnson et al. 
 2005 ). Nerve grafting or nerve conduits are standard procedure in cases like these 
(Siemionow and Brzezicki  2009 ; Pabari et al.  2010 ). During autograft nerve trans-
plants, a nerve segment is transplanted from another region of the same patient. 
Clinically, autografts are accepted as the “gold standard” because of being nonim-
munogenic and having best possible combination of the natural environment 
required for nerve regeneration. Autografts provide bridging of two ends, allowing 
physical adherence guidance and proper support for Schwann cell proliferation. 
On the other hand, they have some drawbacks such as sensation at the donor site, 
creating a second incision in the body, and having a limited supply of the donor 
site. Cadaveric nerve allografts are another option as nerve grafts, which do not 
require a second incision on the patient, however, compel systemic immunosup-
pression (Trumble and Shon  2000 ; Pollard et al.  1971 ; Mackinnon et al.  1982 ; 
Lassner et al.  1989 ; Gulati and Cole  1990 ; Gulati  1998 ). This technique is usually 
preferred in cases like severely damaged segmental nerve loss (Ray and Mackinnon 
 2010 ). Although nerve grafts seem plausible because of their optimal nature for 
regeneration, only 50 % of patients with autograft nerve transplants regain func-
tional nerve regeneration (Lee and Wolfe  2000 ) and the drawbacks of these tech-
niques have led to development of synthetic and biological nerve guidance conduits 
(Fansa et al.  2001 ; Walsh et al.  2009 ; Glasby et al.  1986 ). For this purpose, a pri-
mary concern should be mimicking the native environment of the PNS for optimal 
nerve regeneration. Some of the important points that should be taken into consid-
eration while designing a peripheral construct are supporting axonal migration, 
promotion of viability, and proliferation of Schwann cells; proper storage of growth 
factors; and providing multiple cues from the native ECM (Evans  2000 ). In this 
regard, biodegradable hollow neural guidance channels can be used with ECM 
mimicking matrix fi llers, coatings, and growth factor storing scaffolds. Schwann 
cell transplantation is another alternative that can be delivered within these scaf-
folds (De Luca et al.  2014 ). 
6.2.1  Engineering Topographical and Mechanical Properties 
for Neural Guidance 
 Biocompatible and bioactive  mater ials have been utilized in order to mimic physi-
cal, chemical, and biological properties of the native neural tissue. Cells are dis-
tinctly responsive to every cue in their environment including surface topography, 
stiffness, and interacting fi ber diameter and change their behavior accordingly 
(Georges and Janmey  2005 ; Pedersen and Swartz  2005 ; Khatiwala et al.  2006 ; 
Curtis and Riehle  2001 ). Grooves, micro- and nanofi bers, gels, and fi lms have been 
studied in order to promote and direct neuronal outgrowth and enhance neuronal 
attachment (Xie et al.  2010 ; Sun et al.  2010 ; Mobasseri et al.  2013 ; Daud et al.  2012 ; 
Bell and Haycock  2012 ). Instead of using hollow guidance tubes that lacks physical 
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properties of the native nerve structure, studies have focused on developing materi-
als that guide the axons to the distal site of the injury. Lumen fi lling materials are 
used for this purpose to provide contact, attachment, and growth of the cells (Chen 
et al.  2006 ; Jiang et al.  2010 ). Naturally, Schwann cell basal lamina is a favorable 
environment for physical guidance. It consists primarily of laminin and collagen 
that represent aligned, nanoscale features (Bunge and Bunge  1983 ). Neurite out-
growth of chick  dorsal root ganglia (DRG) neurons was intensely improved on 
aligned nanofi brous surfaces, which demonstrates the importance of these features 
(Kim et al.  2008 ; Corey et al.  2007 ). Incorporating Schwann cells is also a strategy; 
aligned collagen  poly-E-caprolactone (PCL) fi lament constructs seeded with 
Schwann cells have shown that DRG cells had enhanced and oriented neurite out-
growth in vitro (Ribeiro-Resende et al.  2009 ). 
 Along with these factors, porosity of the conduit is also important in axonal 
regeneration. Pores of the conduits enable inward diffusion of ECM proteins and 
growth factors (Kim et al.  1993 ), and outward diffusion of waste products. In addi-
tion to this, infi ltration of connective fi brous tissue should also be prevented (Wang 
et al.  2009 ) and regeneration was observed to proceed into microsized pores (Oh 
et al.  2013 ). Therefore, the pores of the conduits should be wide enough for growth 
factor and waste product diffusion and narrow enough to prevent fi brous tissue 
infi ltration and regeneration toward the pore. “Roll and seal”  model aligned nanofi -
brous conduit-derived pores have been shown to trigger greater neurite outgrowth 
and functional recovery compared to aligned microfi brous conduit-derived pores 
(Jiang et al.  2014 ). 
 Nervous tissue is a soft tissue and is sensitive to the mechanical stiffness of the 
environment. Natural stiffness of the peripheral neural tissue has stiffness value 
between 150 and 300 kPa, whereas glial cells and neurons individually have stiffness 
values ranging from 0.5 to 1.6 kPa (Jalili-Firoozinezhad et al.  2014 ). Therefore, 
resemblance of stiffness to the native environment is an important factor that plays 
role on nerve regeneration. Agarose gel stiffness (density) was showed to have an 
inversely proportional relationship with neurite extension rate of DRG cultures 
(Balgude et al.  2001 ). PEG-based hydrogels have also been studied for nerve regen-
eration purposes and as the stiffness of the PEG-based hydrogel increased, PC12 cells 
showed reduced neurite extension. In addition, below a threshold value of stiffness, 
neurite outgrowth of PC12 cells decreased drastically (Leach et al.  2007 ), which 
proves that neurons require a defi ned range of intermediate stiffness (Hoffman-Kim 
et al.  2010 ). These studies indicate the signifi cance of mechanical properties of native 
nerve tissue in designing biomaterials for peripheral nerve repair. 
6.2.2  Surface Chemistry and Biochemical Modifi cations 
to Increase Nerve Regeneration 
 Nerve guidance conduits  requi re some additional properties such as surface modifi -
cation and some biochemical cues in order to promote axon guidance, Schwann cell 
proliferation, adhesion, and migration (Gu et al.  2014 ). These modifi cations may be 
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in the form of protein coatings, chemical/physical treatment of the surface, or pro-
tein mimetic peptides presented on the biomaterials (Chung and Park  2007 ). In 
order to create the native environment of the healthy nerve tissue, ECM proteins are 
considered to have great potential for functionalization of the conduit surface. 
Collagen, fi bronectin, and laminin are examples of some major components of the 
ECM that have been used for this purpose (Yu and Bellamkonda  2003 ; Armstrong 
et al.  2007 ; Koh et al.  2010 ). Laminin, in particular, has been used most frequently 
for surface modifi cation or ECM mimicking purposes among others due to its abil-
ity to improve neurite extension and provide Schwann cell adhesion, proliferation, 
and migration (Yu and Bellamkonda  2003 ; Silva et al.  2004 ; Yu et al.  1999 ; Itoh 
et al.  2001 ; Rangappa et al.  2000 ; Rutkowski et al.  2004 ; Toba et al.  2001 ; Matsumoto 
et al.  2000 ; Koh et al.  2010 ; Bellamkonda et al.  1995 ). Collagen and fi bronectin also 
have regenerative capacity in terms of Schwann cell adhesion, proliferation, and 
neurite outgrowth improvement; however, outcomes have shown to be signifi cantly 
lower than that of laminin in terms of regeneration (Yu and Bellamkonda  2003 ; 
Armstrong et al.  2007 ; Koh et al.  2010 ). Despite the major impact of ECM protein-
based functionalization of the materials on neural regeneration, they are diffi cult to 
synthesize due to their large size (~900 kDa) (Santiago et al.  2009 ; Itoh et al.  2001 ). 
An alternative to using large ECM protein modifi cations is protein mimetic short 
peptide sequences, which are more stable, less immunogenic, and relatively low 
molecular weight. These short peptides are usually designed to be recognized by the 
cellular receptors and they are represented on a surface. Due to their small size, they 
have a high surface density; thus, there is more interaction for signaling events and 
cell attachment (Itoh et al.  2001 ; Chung and Park  2007 ). 
 A widely used short peptide sequence is  RGD (Arg–Gly–Asp), which is an inte-
grin binding amino acid sequence found in fi bronectin, laminin, and other ECM 
molecules and has been used for inducing cell attachment. IKVAV (Ile–Lys–Val–
Ala–Val) (Tashiro et al.  1989 ) and YIGSR (Tyr–Ile–Gly–Ser–Arg) are found at the 
laminin b chain and RNIAEIIKDI (Arg–Asn–Ile–Ala–Glu–Ile–Ile–Lys–Asp–Ile) 
belongs to laminin g chain, which all mimic laminin. HAV (His–Ala–Val) sequence 
mimics N-cadherin, which is an adhesive and regulatory protein found on both neu-
rons and glial cells (Chung and Park  2007 ; Itoh et al.  2003 ; Santiago et al.  2009 ; 
Itoh et al.  2001 ). Functionality of these peptides has been assessed in various appli-
cations. Adams et al. showed that DRG neurons, that were grown on gradients of 
photoimmobilized  IKVAV bound polystyrene grids, preferentially directed their 
neurites toward higher concentration of IKVAV containing surface (Adams et al. 
 2005 ). In another study, melt coextruded aligned  poly(ε-caprolactone) (PCL) fi bers 
were modifi ed with photochemical gradient of IKVAV peptide, which provided 
directional cues for neuronal outgrowth of PC-12 cells (Kim et al.  2015 ). 
 Schense et al. ( 2000 ) evaluated the effects of fi ve ECM mimetic peptides: RGD, 
IKVAV, YIGSR, RNIAEIIKDI, and HAV within a fi brin matrix. In this study, each 
peptide-coated matrix showed increased neurite extension than uncoated fi brin 
matrix in vitro. Moreover, synergistic effect of the four laminin mimetic peptides 
showed signifi cant increase in terms of neurite outgrowth compared with the single 
peptide-coated matrices (Schense et al.  2000 ). In the in vivo studies of the same 
group, they tested same materials as neural guidance channel fi llings for their 
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regenerative capacity in dorsal root ganglion models. Synergistic effects of four 
laminin mimetic peptides also showed similar effects to the in vitro studies (Schense 
et al.  2000 ). Similarly,  PCL scaffolds with RGD peptide functionalization resulted 
in enhanced Schwann cell adhesion as well as axonal interaction in vivo (Santiago 
et al.  2009 ). 
 Another method to produce  nanofi brous scaffolds , while controlling diameter, 
porosity, and surface morphology, is electrospinning (Pham et al.  2006 ; Subbiah 
et al.  2005 ). A variety of polymers can be electrospun on aluminum surfaces and 
these polymers are also known to contribute to neural regeneration by their nanofi -
brous topography. In addition, their surface can be functionalized by bioactive epi-
topes or chemical groups (Pham et al.  2006 ; Prabhakaran et al.  2008 ). Bellamkonda 
et al. showed that multiple layers of aligned acrylonitrile-methacrylate (PAN-MA) 
nanofi bers stacked within semipermeable nerve guidance tubes showed highly 
aligned and enhanced neurite extension of DRG cultures and in vivo PNS regenera-
tion studies (Clements et al.  2013 ). In another study conducted by Ahmed et al., 
electrospun nanofi bers were biofunctionalized by tenascin-C-derived peptides, 
which increased cell adhesion compared to poly- L -lysine-coated glass surfaces 
(Ahmed et al.  2006 ). 
 Self-assembled  peptide amphiphile (PA) nanofi bers are used as matrices similar 
to ECM characteristics. With these nanostructures, the neural microenvironment 
can be manipulated in a way that ECM mimicking peptides are represented on the 
surfaces of the nanofi bers. These peptide nanofi bers are promising materials due to 
their nonimmunogenic, biodegradable, and bioactive nature (Tan et al.  2012 ). These 
materials consist of a hydrophobic alkyl tail, β-sheet forming amino acids, and a 
hydrophilic bioactive epitope. In aqueous solutions, oppositely charged PA mole-
cules self-assemble into nanofi bers and form gels (Cui et al.  2010 ). Cooperative 
effect of laminin mimetic IKVAV PAs and heparan sulfate proteoglycan-derived 
PAs promoted neurite outgrowth of PC-12 cells signifi cantly. Besides, the inhibi-
tory environment caused by chondroitin sulfate was also overcome by these materi-
als (Mammadov et al.  2012 ). The protein or peptide modifi cation is a signifi cant 
approach for neural guidance conduit functionalization. 
6.2.3  Enhancing Regeneration by Electrical Stimulation 
via Conductive Biomaterials 
 Electrical stimulation is a method to  acc elerate nerve regeneration (Seil and Webster 
 2010 ). Since neurons are electroactive cells, they respond to electrical stimulation 
by neurite extension and differentiation. Both direct and alternating current (DC and 
AC) within a voltage range is known to promote neurite outgrowth. DC was shown 
to enhance increased and directed neurite outgrowth (Borgens et al.  1979 ). One 
mechanism of promotion of neurite outgrowth by electrical stimulation is by upreg-
ulation of growth-associated genes. For instance, cyclic adenosine monophosphate 
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(cAMP) production was upregulated upon electrical stimulation of DRG cells 
(Udina et al.  2008 ). Polyaniline, polypyrrole, polythiophene, and polyacetylene are 
some known conductive substrates (Marquardt and Sakiyama-Elbert  2013 ; Schmidt 
et al.  1997 ). Poly ( D , L -lactide-co-epsilon-caprolactone) (PDLLA/CL) nerve guid-
ance (NGCs) fabricated with polypyrrole enhanced neurite outgrowth compared 
to PDLLA/CL conduits alone (Zhang et al.  2007 ). In another study, high-voltage 
electrical stimulation of PLGA fi lms signifi cantly increased number of total neurites 
and myelinated axons (Bryan et al.  2004 ). 
 Polypyrrole and  polyaniline both have excellent conductive and antioxidant 
properties in terms of cellular stimulation; however, their nonbiodegradable struc-
ture limits their usage in nerve regeneration studies (Gu et al.  2014 ). As an alterna-
tive strategy, blending of these materials with other biodegradable biomaterials has 
been proposed (Ghasemi-Mobarakeh et al.  2011 ). Rivers et al. were successful in 
synthesizing a conductive polymer by binding pyrrole oligomers to thiophene via 
ester linkages, so that ester linkages get cleaved by esterases in vivo (Rivers et al. 
 2002 ). In another study, a block copolymer of polyglycolide and aniline pentamer 
showed electroactivity and degradability (Ding et al.  2007 ). Several studies show 
the effect of electrical stimulation on the axis of neural cell division, neuronal polar-
ity, and directed neurite outgrowth (Nguyen et al.  2013 ; McCaig et al.  2005 ; Yao 
et al.  2011 ). All these studies prove that electrical stimulation has a noteworthy 
effect on axonal regrowth acceleration. 
6.3  Biomaterial Design for Central Nervous System Repair 
 Any damage to CNS can be  destruct ive due to loss of communication between 
healthy neurons, and it can cause neuronal degeneration and eventually cell death. 
Due to the low regeneration capacity of CNS, people with CNS trauma or neuro-
degenerative disorders suffer from lifelong consequences and there is a signifi cant 
demand for new strategies to overcome the progressive cell death as well as to 
induce tissue regeneration. The failure of neurons in the CNS to communicate with 
each other after injury is mostly due to the lack of supporting environment for 
regeneration around the damaged neurons rather than characteristics of the cells 
(Richardson et al.  1980 ). For regeneration process of CNS neurons, fi rst the sur-
vival of injured neuron is required, so that it can connect with its target. However, 
making contact is not enough for functional recovery; remyelination of the axons 
and properly functioning synapses on the target neurons are also required. The 
strategies to generate a biomaterial for central nerve repair should focus on removal 
of inhibitory environment, axon guidance, manipulation of cell signaling, increas-
ing the local concentration of neurotrophic factors and suitable drugs, and provid-
ing artifi cial microenvironment to fi ll the gap occurred as a result of injury (Horner 
and Gage  2000 ). 
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6.3.1  Mimicking Extracellular Matrix of Central Nervous 
System 
 ECM  is the surrounding environment of cells composed of  pro teins such as laminin 
and fi bronectin, glycosaminoglycans, proteoglycans, and different types of soluble 
factors (Zimmermann and Dours-Zimmermann  2008 ). It provides structural, bio-
logical, and chemical support to the cells through modulating cell adhesion, prolif-
eration, migration, cell-to-cell interaction, and differentiation. Within the scope of 
tissue engineering, focusing on the development of in vitro cell culture environ-
ments, which mimic the natural ECM of specifi c cell types has received a lot of 
attention (Holmes  2002 ; Lutolf and Hubbell  2005 ). For nervous system applica-
tions, synthetic materials are especially attractive, because their chemical, mechani-
cal, and physical properties can be specifi cally modifi ed to mimic a particular area 
within the nervous system (Schmidt and Leach  2003 ). 
6.3.1.1  Chemical Signals 
 ECM  protein s regulate cell fate including proliferation, migration, and differentia-
tion through interacting with cell surface receptors. One of the major differences of 
CNS from other systems is the composition of ECM proteins. Many ECM proteins, 
including collagen and fi bronectin, are abundant in other tissues, whereas there is 
almost none in CNS. On the other hand, there are different types of proteoglycans 
present between neurons and glial cells (Li et al.  2012 ). 
 While designing a biomaterial, the chemical signals provided by these specifi c 
proteins can be introduced into the system by incorporating the bioactive sequence 
for specifi c interaction depending on the nature of tissue of interest. For instance, 
 arginine–glycine–aspartate (RGD) peptide sequence derived from fi bronectin was 
found to bind to integrin proteins and function in cell adhesion (Pierschbacher and 
Ruoslahti  1984 ; Prowse et al.  2011 ). Later, several ECM-derived short sequences 
have been identifi ed and used for the interaction with integrin proteins to take ben-
efi t of cell–ECM interactions. Due to the important role of laminin protein in ECM 
of nervous system, laminin-derived short sequences were identifi ed.  Tyrosine–iso-
leucine–glycine–serine–arginine (YIGSR) peptide sequence was used to promote 
cell adhesion in in vitro studies (Graf et al.  1987 ). Another sequence derived from 
laminin, isoleucine–lysine–valine–alanine–valine (IKVAV), was also discovered 
and found to promote neurite outgrowth (Tashiro et al.  1989 ). After the discovery 
of these small peptide sequences, they were included in nanomaterial surfaces with 
different forms and used in both in vitro and in vivo studies. These peptides, rather 
than whole proteins, have become more favorable for tissue engineering studies, 
since they are more stable and easy to synthesize. While fi bronectin-derived syn-
thetic peptide (GRGDS) was used in gellan gum hydrogels to enhance the cell adhe-
sion of neural stem/progenitor cells in in vitro studies (Silva et al.  2012 ), 
laminin-derived IKVAV sequence was used in self-assembled peptide nanofi bers as 
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a therapeutic system in a mouse model of spinal cord injury (SCI) (Tysseling- 
Mattiace et al.  2008 ). 
 Many soluble factors have important roles in NSC differentiation into specifi c 
lineages. Therefore, they can be incorporated within hydrogels to induce neural dif-
ferentiation. For instance, through incorporation of neurotrophin-3 (NT-3) into chi-
tosan hydrogels, NSC differentiation toward neurons was achieved (Li et al.  2009 ). 
On the other hand, when FGF-2 was incorporated into PEG hydrogels, NSCs pre-
ferred to stay at undifferentiated state in spite of the addition of differentiation 
medium (Freudenberg et al.  2009 ). 
 Biomaterial studies have also focused on neurotransmitters, which are important 
chemicals for transfer of messages between the cells of the brain. Acetylcholine- 
like biomimetic polymers, including both a bioactive unit (acetylcholine-like unit) 
and a bioinert unit (PEG unit), were studied with primary hippocampal neurons. 
These polymers have potential therapeutic use in neural tissue applications related 
with neurotransmitter-related diseases such as Alzheimer’s disease through modu-
lating the growth of hippocampal neurons (Tu et al.  2011 ). 
6.3.1.2  Mechanical and Physical Cues 
 Besides the chemical  signals  to induce neural regeneration, mechanical and phys-
ical properties of the biomaterial system, such as stiffness and dimensionality, 
have to be taken into consideration to mimic the natural environment of nervous 
system. Mechanical properties of the material could contribute to differentiation 
into different lineages and sometimes, elasticity of the material can override the 
effect of chemical signals as shown in mesenchymal stem cells, which did not 
display any response to osteogenic growth factors when plated on soft surfaces 
(Engler et al.  2006 ). 
 The mechanical properties of the substrate show highly selective and specifi c 
effects in regenerative studies of central nervous system. Although brain and spinal 
cord are the softest tissues in human body with elastic moduli around 2 kPa, when 
glial scar occurs as a consequence of an injury, stiffness of this local area can 
become higher which forms both physical and chemical obstacles to neurite 
 extension and regeneration in nervous tissue injuries. Soft materials have become 
more favorable in the studies of CNS tissue due to the selective response of neurons 
and astrocytes to matrix stiffness (Georges et al.  2006 ). In addition, gels with low 
elastic moduli were found to selectively induce neuronal development. It was previ-
ously shown that rat adult NSCs primarily differentiated into glial cells when cul-
tured on stiff substrates having elastic moduli between 1 and 10 kPa, whereas soft 
materials primarily gave rise to neurons. Also, the highest amount of neurons was 
obtained when culturing on interpenetrating polymer network hydrogel with elastic 
modulus of 0.5 kPa, which is close to physiological mechanical properties of brain 
tissue (Saha et al.  2008 ). While spinal cord and cortical brain neurons favor soft 
materials to extend their neurites (Balgude et al.  2001 ; Saha et al.  2008 ), astrocytes 
generate stress fi bers and they are more activated on the surfaces with high elastic 
modulus (Georges et al.  2006 ). 
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 Another important factor about the physical structure of the material is the 
dimensionality of the substrate. Although two-dimensional (2D) cell culture studies 
are more commonly preferred because environmental control, cell observation, and 
manipulation are easy, three-dimensional (3D) studies have great importance as 
they provide a more realistic model for in vivo studies. In one study, hippocampal 
neurons were encapsulated into 3D aragonite matrix and compared to ones seeded 
on 2D surface. The cells showed higher survival rate in 3D cell culture compared to 
2D conditions (Peretz et al.  2007 ). Also, Cunha et al. decorated the 3D biomaterial 
scaffold with RGD, BMHP1 (bone marrow homing peptide 1), and BMHP2 motifs, 
for adult NSC culture (Cunha et al.  2011 ). They provided deeper understanding 
about the cell behavior in 3D scaffolds which is required for future clinical applica-
tions. 3D gel matrices were also studied in injured brain model. Laminin-derived 
IKVAV motif was linked to self-assembling peptide RADA (16) to form a func-
tional 3D peptide-based scaffold for NSC encapsulation. Beside differentiation of 
NSCs into neural cell in in vitro conditions, injection of this hydrogel into damaged 
brain tissue to fi ll the cavity and form a bridge for the gap eventually led to improve-
ment in brain tissue regeneration (Cheng et al.  2013 ). 
6.3.2  Approaches for Drug Delivery to Central Nervous System 
 The complexity of the nervous system is  a n important criterion that should be taken 
into consideration while designing a system for drug delivery. Biocompatible mate-
rials for drug delivery are desired to promote neural regeneration through releasing 
the cargo in a controlled manner while maintaining the integrity of healthy tissue. 
However, the presence of BBB and BSCB is the primary problem to deliver drug to 
CNS and limit the effi cacy of drug delivery of therapeutics through forming ana-
tomical, transport, and metabolic barriers. Therefore, different strategies should be 
considered to enhance drug delivery to CNS, including material properties, drug 
selection, and delivery method. 
6.3.2.1  Material Properties and Methods for Drug Delivery 
 While designing new materials for neural  tiss ue engineering, it is important to 
choose appropriate materials for nervous system. The chemical and physical prop-
erties of the material must be well evaluated in order to provide controlled release 
through degradation rate with suitable dimensions for the injected site. Depending 
on the purpose, you can use different synthetic materials with different mechanical 
properties and release profi le so that the immune response can be modifi ed through 
altering the composition of the material. For instance, Poly (ethylene glycol) (PEG) 
has the property to resist cell adhesion and protein adsorption (Alcantar et al.  2000 ), 
which contribute to minimize immune response. Further modifi cations with bioac-
tive epitopes for cell adhesion or mimicking ECM can be used to provide cell 
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migration into the scaffold, which also contributes to regeneration (Benoit and 
Anseth  2005 ; Groll et al.  2005 ). 
 Poly (ethylene-covinyl acetate) (pEVA) is another commonly used delivery sys-
tem used in neural tissue engineering studies since it is a nondegradable and bio-
compatible scaffold, which makes it a favorable choice. Stability is another 
important property of pEVA for drug delivery over an extended period. It has been 
used in nerve growth factor (NGF)- and NT-3-releasing guidance channels to 
induce regeneration in transected rat dorsal root (Bloch et al.  2001 ). 
 To overcome the BBB penetration problem, many different carrier systems have 
been developed and used in neural tissue engineering studies. The techniques used 
as delivery system can be classifi ed as systemic and local delivery. 
 Systemic drug delivery is performed through intravenous or intraperipheral 
injection, but it requires high dosages to fulfi ll the therapeutic effect and can infl u-
ence nontarget tissues due to systemic toxicity. Therefore, while designing systemic 
drug carriers, it is important to provide properties resisting to long circulation and 
favorable surface properties for endothelial cell interaction (Misra et al.  2003 ). For 
systemic drug delivery, liposomes and polymeric NPs have been extensively stud-
ied for brain drug delivery (Garcia-Garcia et al.  2005 ).  Liposomes are biocompati-
ble and biodegradable delivery systems, and their surfaces are generally modifi ed 
with hydrophilic polymers to deal with plasma clearance of liposomes (Lian and Ho 
 2001 ). Generally, poly(ethylene glycol) (PEG) is used for an additional layer, which 
increases blood circulation time of liposome (Garcia-Garcia et al.  2005 ). For pene-
tration of liposomes through BBB, the carrier system can be developed by active 
targeting, which modifi es the distribution of liposomes through an antibody or a 
ligand conjugation that is eventually recognized by the receptor specifi c to target 
tissue (Schnyder and Huwyler  2005 ). Therefore, by combining the effect of PEG on 
extended circulation time and specifi city due to an antibody or a ligand conjugation, 
delivery can be obtained through the BBB. Liposomes have been used for the treat-
ment of CNS diseases including brain tumors, infection, and ischemia (Zhong and 
Bellamkonda  2008 ). 
 Polymeric nanoparticles (NPs) ranging from 10 to 1000 nm in size can be used 
as carrier polymers encapsulated or covalently attached to therapeutic drugs 
(Lockman et al.  2002 ). Polymeric NPs are more stable against the biological fl uids 
when compared to liposomes. Moreover, their structures are more suitable for con-
trolled and sustained drug release over a period of time after injection. Generally, 
poly(alkylcyanoacrylates) (PACAs), polyacetates, polysaccharides, and copoly-
mers are used for NP synthesis (Garcia-Garcia et al.  2005 ). For instance, drugs 
including dalargin, loperamide, tubocurarine, and doxorubicin have been delivered 
to the CNS by Polybutylcyanoacrylate (PBCA) NPs (Zhong and Bellamkonda 
 2008 ). NPs can also be coated with hydrophilic polymers, such as PEG, to increase 
their uptake (Brigger et al.  2002 ). 
 To manage systemic toxicity of the drugs and increase their effectiveness, 
local delivery systems are favorable. Local delivery of therapeutic drugs with a 
biocompatible carrier provides an advantageous method at the target region. This 
approach also bypasses the BBB penetration problem. For CNS, PLGA and poly-
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anhydride poly [bis(p-carboxyphenoxy)] propane-sebacic acid (PCPP-SA) are 
most commonly used biodegradable polymers for local drug delivery. For instance, 
PLGA microspheres were used as local delivery for antitumor agents such as 5-fl u-
orouracil and platelet factor 4 fragment to treat brain tumors (Benny et al.  2005 ; 
Menei et al.  1996 ). PLGA microspheres were also used for neurodegenerative 
 diseases. Dopamine and noradrenaline delivery with PLGA microspheres was used 
as a therapeutic strategy for Parkinson’s disease (McRae and Dahlstrom  1994 ). 
Also, PLGA microparticles were used as NGF carriers for the protection of neu-
rons from excitotoxin- induced lesions (Benoit et al.  2000 ). 
6.3.2.2  Drug Selection 
 Depending on the tissue  typ e to be regenerated, a specifi c therapeutic drug or com-
bination of different drugs can be selected. Within the potential therapeutic drugs 
for neural tissue engineering, neurotrophins are the most common growth factors 
used for neural regeneration. Neurotrophins are composed of NGF, brain-derived 
neurotrophic factor (BDNF), NT-3, and neurotrophin-4/5. For instance, NGF works 
both in PNS and CNS. It especially enhances survival of cholinergic neurons, which 
makes it attractive for therapeutic studies against neurodegenerative disorders such 
as Alzheimer’s disease (Siegel and Chauhan  2000 ). However, while designing a 
delivery system, it is important to know the right place to inject and dose required, 
because NGF can cause unwanted sensory neural fi ber sprouting which terminally 
can cause chronic pain (Romero et al.  2001 ). In addition to NGF, NT-3 functions in 
neurogenesis through promoting the differentiation of new neurons. Moreover, 
studies have shown that NT-3 can promote cell survival and neurite outgrowth in 
motor neurons after spinal cord injury (Bloch et al.  2001 ; Grill et al.  1997 ). 
 Anti-infl ammatory drugs can also be used in drug delivery systems to suppress 
chronic infl ammation and immune response caused by implantation. Among these 
anti-infl ammatory drugs, dexamethasone is one of the most commonly used drugs 
for this purpose. Although it is generally used to treat infl ammatory diseases includ-
ing arthritis and multiple sclerosis, some studies revealed promising results in neu-
ral tissue applications (Kim and Martin  2006 ). 
 Another drug category used for delivery systems in CNS is chemotherapeutic 
agents. Since chemotherapeutic agents can also affect nontarget tissues and cause 
systemic toxicity, targeted delivery of these drugs is quite critical and important. 
 Glioblastoma is one of the most aggressive cancer types with short survival rates. 
The chemotherapeutic drugs cannot access to the brain by traditional chemotherapy 
applications because of the presence of BBB. Therefore, therapeutic potential of 
these drugs can be modifi ed with delivery systems. For example, doxorubicin, one 
of the most potent antitumor agents, has been attached to the surface of poly(butyl 
cyanoacrylate) nanoparticles coated with polysorbate 80 and this drug was success-
fully transported into the brain to treat brain tumors (Gulyaev et al.  1999 ). 
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6.4  Concluding Remarks 
 Nervous system is the most complex system in the body due to the complex interac-
tions of the cells with each other. Also, due to poor regeneration capacity of nervous 
system, development of new strategies for repair and regeneration of this system is 
in high demand. Moreover, lack of clinically available successful therapies makes 
these therapeutic studies more attractive. Biomaterials have been widely studied up 
to now and they provide highly promising strategies in treatment for disorders of 
nervous system. They can be tailored at molecular level and their structural and 
biochemical properties can be tuned, which allows improvement of therapeutic 
methods according to the purpose of treatment. Looking ahead, a wide range of 
materials, such as polymers and synthetic self-assembled systems, have already 
been developed, but it is still essential to generate other biomaterials considering the 
nature and all requirements of the tissue including physical, chemical, and biologi-
cal demands. 
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